KUALA LUMPUR: Pharmaniaga Berhad has selected Oracle Fusion Cloud Supply Chain and Manufacturing (SCM) to improve logistics processes in preparation for Covid-19 vaccine distribution in Malaysia.
The adoption of Oracle Cloud SCM will enable Pharmaniaga to automate planning and execution processes, and at the same time enable the company to gain real-time shipment insights to improve the efficiency and security of its logistics operation.
Pharmaniaga said it needed a cloud-based logistics platform to automate manual processes and improve the traceability and security of its cold chain services.
“We’ve been delivering vaccines to health facilities in Malaysia for more than 25 years and have strong cold chain infrastructure, but we needed to reduce manual processes to meet the monumental challenge of distributing the Covid-19 vaccine,” Pharmaniaga Berhad’s director of logistics and distribution, Abdul Malik Mohamed.
“With Oracle Cloud SCM’s logistics and IoT applications, we will be better positioned to efficiently and safely deliver the Covid-19 vaccine across Malaysia,” he said.
By offering solutions that enhance planning and real-time decision-making, such as Oracle Transportation Management and Oracle Internet of Things (IoT) Intelligent Applications, Oracle Cloud SCM helps customers identify new opportunities, rethink processes, and plan and execute across the entire business.
Oracle said with Oracle Transportation Management, Pharmaniaga can automate logistics planning and execution and improve efficiency, while the Oracle IoT Intelligent Applications will help monitor cargo temperature and vehicle routes to validate the quality of products and enhance security.
“Unprecedented demand for the Covid-19 vaccine will create cold chain complexity unlike anything we’ve ever seen,” said Oracle Malaysia’s vice president, Software as a Service (SaaS), Jasbir Singh.
“Streamlining logistics processes and enhancing shipment tracking with Oracle Cloud SCM can enable Pharmaniaga to rise to this challenge and scale its operations to support the immunization of Malaysia’s 32 million residents,” he said.